Feed 6973.TWO
69
U-Neuron Biomedical Inc
6973.TWO · TWO
$37.10 +0.00% (+$0.00)
1M +13.26%
Market Cap $1.4B
P/E Ratio -
Div. Yield -
ROE -
Valuation
44 /100
Fair P/B 2.01x
P/S 17.26x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 63.31%
Rev. growth 45.59%
FCF growth N/A
Profitability
20 /100
Weak Net margin 66.89%
Op. margin 78.85%
FCF margin 103.53%
Quality
2 /100
Poor ROA 7.24%
Asset turnover 0.11x
ROIC 8.96%
Debt
100 /100
Low Current ratio 16.48x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
32 /100
Unstable Rev. volatility 42.95%
EPS volatility 32.23%
Profitable years 0
Vprašajte StockBota o 6973.TWO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Hsiao Min Huang
Employees
30
Headquarters
New Taipei City